Follow
Iris R. Hartley
Iris R. Hartley
National Institute of Dental and Cranial Facial Research
Verified email at nih.gov
Title
Cited by
Cited by
Year
Tumor-induced osteomalacia
P Florenzano, IR Hartley, M Jimenez, K Roszko, RI Gafni, MT Collins
Calcified Tissue International 108, 128-142, 2021
1172021
Fibrous dysplasia of bone and McCune–Albright syndrome: a bench to bedside review
I Hartley, M Zhadina, MT Collins, AM Boyce
Calcified tissue international 104, 517-529, 2019
702019
Prospective phenotyping of long-term survivors of generalized arterial calcification of infancy (GACI)
CR Ferreira, ME Hackbarth, SG Ziegler, KS Pan, MS Roberts, DR Rosing, ...
Genetics in Medicine 23 (2), 396-407, 2021
512021
Targeted FGFR blockade for the treatment of tumor-induced osteomalacia
IR Hartley, CB Miller, GZ Papadakis, C Bergwitz, J Del Rivero, JE Blau, ...
New England Journal of Medicine 383 (14), 1387-1389, 2020
272020
Pheochromocytoma and paraganglioma patients with poor survival often show brown adipose tissue activation
Z Abdul Sater, A Jha, A Hamimi, A Mandl, IR Hartley, S Gubbi, M Patel, ...
The Journal of Clinical Endocrinology & Metabolism 105 (4), 1176-1185, 2020
202020
Autosomal dominant hypocalcemia type 1: A systematic review
KL Roszko, LM Stapleton Smith, AV Sridhar, MS Roberts, IR Hartley, ...
Journal of Bone and Mineral Research 37 (10), 1926-1935, 2020
122020
PTH and FGF23 exert interdependent effects on renal phosphate handling: evidence from patients with hypoparathyroidism and hyperphosphatemic familial tumoral calcinosis treated …
D Ovejero, IR Hartley, LF de Castro Diaz, E Theng, X Li, RI Gafni, ...
Journal of Bone and Mineral Research 37 (2), 179-184, 2020
122020
Diverticular perforation: a fatal complication to forestall in Cushing syndrome
ZA Sater, S Jha, R McGlotten, I Hartley, M El Lakis, KA Araque, ...
The Journal of Clinical Endocrinology & Metabolism 103 (8), 2811-2814, 2018
122018
A cross sectional cohort study of the effects of FGF23 deficiency and hyperphosphatemia on dental structures in hyperphosphatemic familial tumoral calcinosis
AE Lee, EY Chu, PJ Gardner, O Duverger, A Saikali, SK Wang, RI Gafni, ...
Journal of Bone and Mineral Research Plus 5 (5), e10470, 2021
102021
Determination of FGF23 levels for the diagnosis of FGF23‐mediated hypophosphatemia
IR Hartley, RI Gafni, KL Roszko, SM Brown, LF de Castro, A Saikali, ...
Journal of Bone and Mineral Research 37 (11), 2174-2185, 2020
92020
Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor Induced Osteomalacia
IR Hartley, KL Roszko, X Li, K Pozo, J Streit, J Rivero, MT Magone, ...
Journal of Bone and Mineral Research Plus 6 (8), e10661, 2022
82022
Ocular adverse effects of infigratinib, a new fibroblast growth factor receptor tyrosine kinase inhibitor
MT Magone, IR Hartley, E Fitzgibbon, R Bishop, M Arango, S Moran, ...
Ophthalmology 128 (4), 624-626, 2021
82021
Consideration of ICD-9 code-derived disease-specific safety indicators in CKD
IR Hartley, JS Ginsberg, CJ Diamantidis, M Zhan, L Walker, GB Rattinger, ...
Clinical Journal of the American Society of Nephrology 8 (12), 2123-2131, 2013
62013
The effects of Encaleret (CLTX-305) on mineral physiology in autosomal dominant hypocalcemia type 1 (ADH1) demonstrate proof-of-concept: early results from an ongoing phase 2b …
RI Gafni, IR Hartley, KL Roszko, EF Nemeth, KA Pozo, R Sani-Grosso, ...
Journal of the Endocrine Society 5 (Supplement_1), A269-A269, 2021
52021
Burosumab for Tumor‐Induced Osteomalacia: Not Enough of a Good Thing
IR Hartley, MT Collins
Journal of Bone and Mineral Research 36 (12), 2453-2454, 2020
42020
SUN-364 enthesophytes are a common feature of FGF23-mediated hypophosphatemia due to tumor-induced osteomalacia
RI Gafni, EJ Spector, IR Hartley, B Redd, GL Mitnik, MT Collins
Journal of the Endocrine Society 4 (Supplement_1), SUN-364, 2020
22020
Effects of Encaleret on Corrected QT Interval in Autosomal Dominant Hypocalcemia Type 1: Early Results From an Ongoing Phase 2b, Open-Label, Dose-Ranging Study
I Hartley, R Gafni, K Roszko, K Pozo, MT Collins, E Nemeth, ...
Circulation 144 (Suppl_1), A14476-A14476, 2021
12021
A Phase 2B, Open-Label, Dose-Ranging Study of Encaleret (CLTX-305) in Autosomal Dominant Hypocalcemia Type 1 (ADH1)
RI Gafni, IR Hartley, KL Roszko, EF Nemeth, KA Pozo, R Sani-Grosso, ...
Journal of the Endocrine Society 5 (Suppl 1), A253, 2021
12021
Hungry Bone Syndrome in Tumor-Induced Osteomalacia
LN Raborn, IR Hartley, KS Pan, G Woods, KA Pozo, J Streit, MT Collins, ...
JOURNAL OF BONE AND MINERAL RESEARCH 35, 110-111, 2020
12020
Cushing disease in a patient with nonbullous congenital ichthyosiform erythroderma: lessons in avoiding glucocorticoids in ichthyosis
IR Hartley, J Costa Beber Nunes, M Lodish, CA Stratakis
Journal of Pediatric Endocrinology and Metabolism 32 (8), 911-914, 2019
12019
The system can't perform the operation now. Try again later.
Articles 1–20